Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?

被引:18
作者
Asakura, Hitoshi
Suzuki, Kenji
Honma, Terasu
机构
[1] Niigata Univ, Int Med Informat Ctr, Niigata 95021, Japan
[2] Niigata Univ, Med & Dent Hosp, Dept Internal Med, Niigata 95021, Japan
[3] Niigata Prefectural Shibata Hosp, Dept Internal Med, Niigata, Japan
关键词
ulcerative colitis; Crohn's disease; inflammatory bowel disease; treatment; immunology;
D O I
10.3748/wjg.v13.i15.2145
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There are four steps in the interaction between intestinal microbes and mucosal inflammation in genetically predisposed individuals from the viewpoints of basic and clinical aspects of inflammatory bowel disease (IBD). The first step is an interaction between intestinal microbes or their components and intestinal epithelial cells via receptors, the second step an interaction between macrophages and dendritic cells and mucosal lymphocytes, the third step an interaction between lymphocytes and vascular endothelial cells, and the fourth step an interaction between lymphocytes and granulocytes producing proinflammatory cytokines or free radicals and mucosal damage and repair. Recent therapeutic approaches for IBD aim to block these four steps in the intestinal inflammation of patients with IBD. (c) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:2145 / 2149
页数:5
相关论文
共 51 条
[1]
Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis [J].
Anezaki, K ;
Asakura, H ;
Honma, T ;
Ishizuka, K ;
Funakoshi, K ;
Tsukada, Y ;
Narisawa, R .
INTERNAL MEDICINE, 1998, 37 (03) :253-258
[2]
Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease [J].
Arai, F ;
Takahashi, T ;
Furukawa, K ;
Matsushima, K ;
Asakura, H .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (09) :2071-2079
[3]
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis [J].
Bibiloni, R ;
Fedorak, RN ;
Tannock, GW ;
Madsen, KL ;
Gionchetti, P ;
Campieri, M ;
De Simone, C ;
Sartor, RB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1539-1546
[4]
Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease [J].
Brimnes, J ;
Allez, M ;
Dotan, I ;
Shao, L ;
Nakazawa, A ;
Mayer, L .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5814-5822
[5]
A regenerative role for bone marrow following experimental colitis: Contribution to neovasculogenesis and myofibroblasts [J].
Brittan, M ;
Chance, V ;
Elia, G ;
Poulsom, R ;
Alison, MR ;
MacDonald, TT ;
Wright, NA .
GASTROENTEROLOGY, 2005, 128 (07) :1984-1995
[6]
Defects in mucosal immunity leading to Crohn's disease [J].
Cobrin, GM ;
Abreu, MT .
IMMUNOLOGICAL REVIEWS, 2005, 206 :277-295
[7]
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients [J].
Danese, S ;
Katz, JA ;
Saibeni, S ;
Papa, A ;
Gasbarrini, A ;
Vecchi, M ;
Fiocchi, C .
GUT, 2003, 52 (10) :1435-1441
[8]
Angiogenesis as a novel component of inflammatory bowel disease pathogenesis [J].
Danese, Silvio ;
Sans, Miquel ;
De La Motte, Carol ;
Graziani, Cristina ;
West, Gail ;
Phillips, Manijeh H. ;
Pola, Roberto ;
Rutella, Sergio ;
Willis, Joe ;
Gasbarrini, Antonio ;
Fiocchi, Claudio .
GASTROENTEROLOGY, 2006, 130 (07) :2060-2073
[9]
Probiotics and prebiotics in chronic inflammatory bowel diseases [J].
Ewaschuk, Julia B. ;
Dieleman, Levinus A. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (37) :5941-5950
[10]
Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study [J].
Fukuda, Y ;
Matsui, T ;
Suzuki, Y ;
Kanke, K ;
Matsumoto, T ;
Takazoe, M ;
Matsumoto, T ;
Motoya, S ;
Honma, T ;
Sawada, K ;
Yao, T ;
Shimoyama, T ;
Hibi, T .
JOURNAL OF GASTROENTEROLOGY, 2004, 39 (12) :1158-1164